Cas 1192853-19-2,5-cyclohexylmethoxy-3-[1,2,3]triazolo[4,5-b]pyridin-1-ylmethyl-benzene-1,2-diol

1192853-19-2

Post Buying Request

Basic information

Product Name: 5-cyclohexylmethoxy-3-[1,2,3]triazolo[4,5-b]pyridin-1-ylmethyl-benzene-1,2-diol
Synonyms: 5-cyclohexylmethoxy-3-[1,2,3]triazolo[4,5-b]pyridin-1-ylmethyl-benzene-1,2-diol
CAS NO:1192853-19-2
Molecular Formula:
Molecular Weight: 354.409
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 5-cyclohexylmethoxy-3-[1,2,3]triazolo[4,5-b]pyridin-1-ylmethyl-benzene-1,2-diol(CAS DataBase Reference)
NIST Chemistry Reference: 5-cyclohexylmethoxy-3-[1,2,3]triazolo[4,5-b]pyridin-1-ylmethyl-benzene-1,2-diol(1192853-19-2)
EPA Substance Registry System: 5-cyclohexylmethoxy-3-[1,2,3]triazolo[4,5-b]pyridin-1-ylmethyl-benzene-1,2-diol(1192853-19-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1192853-19-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1192853-19-2 Suppliers

Recommended suppliers

1192853-19-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1192853-19-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,2,8,5 and 3 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1192853-19:
(9*1)+(8*1)+(7*9)+(6*2)+(5*8)+(4*5)+(3*3)+(2*1)+(1*9)=172
172 % 10 = 2
So 1192853-19-2 is a valid CAS Registry Number.

1192853-19-2Upstream product

1192853-63-6 C₂₅H₃₀N₄O₃

1192853-19-2Downstream Products

1192853-19-2Relevant academic research and scientific papers

A new structural class of S-adenosylhomocysteine hydrolase inhibitors

Kim, Byung Gyu,Chun, Tae Gyu,Lee, Hee-Yoon,Snapper, Marc L.

supporting information; experimental part, p. 6707 - 6714 (2009/12/06)

Effective inhibitors of S-adenosylhomocysteine hydrolase hold promise towards becoming useful therapeutic agents. Since most efforts have focused on the development of nucleoside analog inhibitors, issues regarding bioavailability and selectivity have bee

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1192853-19-2